BAY86-5028, Mirena extension, contraception
Research payments
$64,714
Through program year 2023, $64,714 in research payments was reported against BAY86-5028, Mirena extension, contraception, across 30 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $3,876 | 1 |
| 2022 | Research | $60,838 | 29 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Catherine Brainard Tucson, AZ Named on 6 payments
- Daniel Harnsberger Chattanooga, TN Named on 5 payments
- Kirk Brody Chattanooga, TN Named on 5 payments
- Mark Akin Austin, TX Named on 3 payments
- Michael Scutella Erie, PA Named on 2 payments
- Juan Reina Franklin, OH Named on 2 payments
- Robin Kroll Seattle, WA Named on 2 payments
- Katharine White Boston, MA Named on 1 payment
- Paula Castano New York, NY Named on 1 payment
- Julie Braga Lebanon, NH Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.